Aurora Cannabis Inc. (TSE:ACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. Three ...
Analysts at Roth Capital issued their Q1 2026 earnings per share estimates for shares of Aurora Cannabis in a research report issued on Thursday, February 6th. Roth Capital analyst W. Kirk expects ...
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the ...
On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...
As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...
Shares of Aurora Cannabis Inc. ACB shed 4.68% to $6.31 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.41% to ...
Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...
Aurora Cannabis Inc. (ACB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback